SIGYN THERAPEUTICS, INC. (SIGY) Operating income 2015–2024
SIGYN THERAPEUTICS, INC. (SIGY) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2024 · since FY2015: -$2.3M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.5M | -2.6% |
| FY2023 | -$2.5M | -14.3% |
| FY2022 | -$2.1M | -6.9% |
| FY2021 | -$2.0M | -119.1% |
| FY2020 | -$916,434 | -76.9% |
| FY2019 | -$517,958 | +48.4% |
| FY2018 | -$1.0M | +50.5% |
| FY2017 | -$2.0M | — |
| FY2015 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SIGY financial trends
SIGY RevenueSIGY Net incomeSIGY Net marginSIGY Gross profitSIGY Gross marginSIGY Operating marginSIGY Operating cash flowSIGY Free cash flowSIGY Capital expendituresSIGY Return on equitySIGY Stock buybacksSIGY Dividends paidSIGY Total assetsSIGY Total liabilitiesSIGY Shareholders’ equitySIGY overview →